Radiolabeled somatostaitin analogs in the treatment of neuroendocrine tumors: experience of the National Cancer Institute of Milano using high dose of 111In-pentetreotide in metastatic neuroendocrine gastroenteropancreatic tumors.

E. Bombardieri; E. Seregni; G. Savelli; C. Villano; M. R. Castellani; F. Cirillo; F. Pallotti; S. Fracassi; C. Chiesa; A. Chiti; E. Bajetta

Radiolabeled somatostaitin analogs in the treatment of neuroendocrine tumors: experience of the National Cancer Institute of Milano using high dose of 111In-pentetreotide in metastatic neuroendocrine gastroenteropancreatic tumors.

E. Bombardieri, E. Seregni, G. Savelli, C. Villano, M. R. Castellani, F. Cirillo, F. Pallotti, S. Fracassi, C. Chiesa, A. Chiti, E. Bajetta

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	63-69
Number of pages	7
Journal	Journal of Endocrinological Investigation
Volume	26
Issue number	8 Suppl
Publication status	Published - 2003

ASJC Scopus subject areas

Endocrinology

Cite this

Bombardieri, E., Seregni, E., Savelli, G., Villano, C., Castellani, M. R., Cirillo, F., Pallotti, F., Fracassi, S., Chiesa, C., Chiti, A., & Bajetta, E. (2003). Radiolabeled somatostaitin analogs in the treatment of neuroendocrine tumors: experience of the National Cancer Institute of Milano using high dose of 111In-pentetreotide in metastatic neuroendocrine gastroenteropancreatic tumors. Journal of Endocrinological Investigation, 26(8 Suppl), 63-69.

Radiolabeled somatostaitin analogs in the treatment of neuroendocrine tumors : experience of the National Cancer Institute of Milano using high dose of 111In-pentetreotide in metastatic neuroendocrine gastroenteropancreatic tumors. / Bombardieri, E.; Seregni, E.; Savelli, G.; Villano, C.; Castellani, M. R.; Cirillo, F.; Pallotti, F.; Fracassi, S.; Chiesa, C.; Chiti, A.; Bajetta, E.

In: Journal of Endocrinological Investigation, Vol. 26, No. 8 Suppl, 2003, p. 63-69.

Research output: Contribution to journal › Article › peer-review

Bombardieri, E, Seregni, E, Savelli, G, Villano, C, Castellani, MR, Cirillo, F, Pallotti, F, Fracassi, S , Chiesa, C , Chiti, A & Bajetta, E 2003, 'Radiolabeled somatostaitin analogs in the treatment of neuroendocrine tumors: experience of the National Cancer Institute of Milano using high dose of 111In-pentetreotide in metastatic neuroendocrine gastroenteropancreatic tumors.', Journal of Endocrinological Investigation, vol. 26, no. 8 Suppl, pp. 63-69.

Bombardieri E, Seregni E, Savelli G, Villano C, Castellani MR, Cirillo F et al. Radiolabeled somatostaitin analogs in the treatment of neuroendocrine tumors: experience of the National Cancer Institute of Milano using high dose of 111In-pentetreotide in metastatic neuroendocrine gastroenteropancreatic tumors. Journal of Endocrinological Investigation. 2003;26(8 Suppl):63-69.

Bombardieri, E. ; Seregni, E. ; Savelli, G. ; Villano, C. ; Castellani, M. R. ; Cirillo, F. ; Pallotti, F. ; Fracassi, S. ; Chiesa, C. ; Chiti, A. ; Bajetta, E. / Radiolabeled somatostaitin analogs in the treatment of neuroendocrine tumors : experience of the National Cancer Institute of Milano using high dose of 111In-pentetreotide in metastatic neuroendocrine gastroenteropancreatic tumors. In: Journal of Endocrinological Investigation. 2003 ; Vol. 26, No. 8 Suppl. pp. 63-69.

@article{cb6771e1000348ba8a348e08778d09ac,

title = "Radiolabeled somatostaitin analogs in the treatment of neuroendocrine tumors: experience of the National Cancer Institute of Milano using high dose of 111In-pentetreotide in metastatic neuroendocrine gastroenteropancreatic tumors.",

author = "E. Bombardieri and E. Seregni and G. Savelli and C. Villano and Castellani, {M. R.} and F. Cirillo and F. Pallotti and S. Fracassi and C. Chiesa and A. Chiti and E. Bajetta",

year = "2003",

language = "English",

volume = "26",

pages = "63--69",

journal = "Journal of Endocrinological Investigation",

issn = "0391-4097",

publisher = "Springer International Publishing",

number = "8 Suppl",

}

TY - JOUR

T1 - Radiolabeled somatostaitin analogs in the treatment of neuroendocrine tumors

T2 - experience of the National Cancer Institute of Milano using high dose of 111In-pentetreotide in metastatic neuroendocrine gastroenteropancreatic tumors.

AU - Bombardieri, E.

AU - Seregni, E.

AU - Savelli, G.

AU - Villano, C.

AU - Castellani, M. R.

AU - Cirillo, F.

AU - Pallotti, F.

AU - Fracassi, S.

AU - Chiesa, C.

AU - Chiti, A.

AU - Bajetta, E.

PY - 2003

Y1 - 2003

UR - http://www.scopus.com/inward/record.url?scp=3543070432&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3543070432&partnerID=8YFLogxK

M3 - Article

C2 - 15233216

AN - SCOPUS:3543070432

VL - 26

SP - 63

EP - 69

JO - Journal of Endocrinological Investigation

JF - Journal of Endocrinological Investigation

SN - 0391-4097

IS - 8 Suppl

ER -

Radiolabeled somatostaitin analogs in the treatment of neuroendocrine tumors: experience of the National Cancer Institute of Milano using high dose of 111In-pentetreotide in metastatic neuroendocrine gastroenteropancreatic tumors.

ASJC Scopus subject areas

Other files and links

Cite this